# Lotus Eye Hospital And Institute Ltd (LOTUSEYE)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹109.19
Day Change: +1.26%
52W High: ₹147.6
52W Low: ₹68
Market Cap: ₹223 Cr

## Valuation
P/E: 334.38
P/B: 3.41
EPS: ₹0.32
Book Value: ₹31.41
Dividend Yield: 0%

## Returns
1Y Return: -9.72%

## Profitability
ROE: 0%
ROCE: 1.51%
Debt/Equity: 0.08
Revenue Growth: 10.6%
Profit Growth: 0%
EBITDA Margin: 4.22%
Operating Margin: -2.4%

## About
Lotus Eye Hospital And Institute Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Lotus Eye Hospital And Institute Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Announcement: Non-Applicability Of SEBI Circular On Large Corporates
- BSE Filing: Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:13.396Z
Price History Updated: 2026-05-25T05:35:43.575Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:35:43.575Z
Quant Updated: 2026-05-25T05:35:43.575Z
Sentiment Updated: 2026-05-25T05:35:43.575Z
Financials Status: current
Financials Updated: 2026-05-18T23:02:52.862Z
Financials Last Attempt: 2026-05-18T23:02:52.862Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹48.6 Cr
Operating Profit: ₹0.55 Cr (OPM 1.13%)
Net Profit: ₹0.74 Cr
Tax: ₹0.64 Cr

## Annual P&L History
FY25: Rev ₹48.6Cr | PAT ₹0.74Cr | OPM 1.13%
FY24: Rev ₹47.24Cr | PAT ₹2.91Cr | OPM 6.16%
FY23: Rev ₹45.98Cr | PAT ₹4.08Cr | OPM 10.24%

## Balance Sheet (FY25)
Total Assets: ₹69.57 Cr
Total Liabilities: ₹9.57 Cr
Borrowings: ₹3.43 Cr
Cash: ₹2.01 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sangeetha  Sundaramoorthy, MD & Director
- Ramanujam  Reghunathan, Chief Financial Officer
- Rajkumar  Sundaramoorthy, Vice President of Administration
- Prathish  S., Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/lotuseye
Disclaimer: For research and education only. Not investment advice.